MYCIO Wealth Partners’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-3,686
Closed -$240K 169
2019
Q4
$240K Buy
3,686
+27
+0.7% +$1.76K 0.02% 297
2019
Q3
$232K Buy
3,659
+205
+6% +$13.4K 0.02% 278
2019
Q2
$233K Buy
3,454
+48
+1% +$3.16K 0.02% 280
2019
Q1
$221K Buy
3,406
+28
+0.8% +$1.86K 0.02% 264
2018
Q4
$211K Sell
3,378
-1,298
-28% -$90.7K 0.02% 256
2018
Q3
$361K Sell
4,676
-2,998
-39% -$226K 0.04% 189
2018
Q2
$544K Buy
7,674
+5
+0.1% +$353 0.06% 146
2018
Q1
$578K Sell
7,669
-2,943
-28% -$234K 0.07% 121
2017
Q4
$766K Buy
10,612
+186
+2% +$14.1K 0.08% 99
2017
Q3
$844K Buy
10,426
+338
+3% +$25.8K 0.1% 95
2017
Q2
$714K Sell
10,088
-58
-0.6% -$3.86K 0.08% 105
2017
Q1
$689K Buy
10,146
+1,165
+13% +$81.9K 0.08% 113
2016
Q4
$643K Sell
8,981
-348
-4% -$25.9K 0.09% 103
2016
Q3
$738K Sell
9,329
-1,144
-11% -$92.9K 0.12% 77
2016
Q2
$874K Buy
10,473
+762
+8% +$67.6K 0.15% 62
2016
Q1
$892K Buy
9,711
+2,759
+40% +$249K 0.16% 59
2015
Q4
$703K Buy
6,952
+1,083
+18% +$113K 0.13% 72
2015
Q3
$576K Buy
5,869
+1,035
+21% +$115K 0.12% 70
2015
Q2
$566K Sell
4,834
-1,193
-20% -$130K 0.11% 75
2015
Q1
$591K Buy
6,027
+900
+18% +$91.4K 0.12% 70
2014
Q4
$483K Buy
5,127
+1,339
+35% +$138K 0.1% 84
2014
Q3
$403K Sell
3,788
-182
-5% -$17.8K 0.09% 86
2014
Q2
$329K Buy
3,970
+220
+6% +$17.1K 0.07% 100
2014
Q1
$266K Sell
3,750
-840
-18% -$65.9K 0.06% 115
2013
Q4
$345K Buy
4,590
+800
+21% +$55.7K 0.09% 96
2013
Q3
$238K Buy
3,790
+300
+9% +$17.9K 0.06% 114
2013
Q2
$179K Buy
+3,490
New +$182K 0.05% 123

Other funds holding GILD

MYCIO Wealth Partners's GILD Position: Q1 2020 in Review

MYCIO Wealth Partners sold out of Gilead Sciences (GILD) in Q1 2020, closing a stake of 3,686 shares — an estimated $240K sold.

MYCIO Wealth Partners first reported a position in GILD in Q2 2013 and held it in 27 quarters. The position peaked at $892K in Q1 2016. 1,643 funds tracked by Wall St. Rank hold GILD as of Q1 2020.

  • MYCIO Wealth Partners reported no remaining Gilead Sciences position as of Q1 2020 after selling out during the quarter.
  • MYCIO Wealth Partners sold 3,686 Gilead Sciences shares in Q1 2020, an estimated $240K.
  • MYCIO Wealth Partners first reported a position in Gilead Sciences in Q2 2013 and held it in 27 quarters.
  • MYCIO Wealth Partners's Gilead Sciences position peaked at $892K in Q1 2016.
  • 1,643 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2020.

Based on MYCIO Wealth Partners's 13F filing for Q1 2020, filed 14 May 2020.